Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...

Novo Nordisk A/S’s obesity shot Wegovy also prevents strokes, heart attacks and death. The price of those benefits is far ...

This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the ...

Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.

WASHINGTON (NEXSTAR) — Americans face a hefty price tag for diabetes and weight-loss drugs. “The people of the United States ...

A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic shift these medications will have on the industry.